Statin‐disclosed acid maltase deficiency
Authors:
- N. C. VoermansNVN. C. Voermans
- M. LammensMLM. Lammens
- R. A. WeversRWR. A. Wevers
- B. G. van EngelenBEB. G. van Engelen
- 14 July 2005
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 258 (2) , 196-197
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscleBiochemical and Biophysical Research Communications, 2005
- Risk for fatal statin-induced rhabdomyolysis as a consequence of misinterpretation of 'evidence-based medicine'Journal of Internal Medicine, 2005
- Current overview of statin-induced myopathyThe American Journal of Medicine, 2004
- Statin-Associated MyopathyJAMA, 2003
- Risk for Myopathy With Statin Therapy in High-Risk PatientsArchives of internal medicine (1960), 2003
- Cerivastatin and Reports of Fatal RhabdomyolysisNew England Journal of Medicine, 2002